Androgens used for testosterone replacement therapy organized by route of administration chart.
Type 2 diabetes mellitus continues to increase in prevalence among older adults, with significant associated morbidity and mortality. The authors of this study examined the cardiovascular effects of liraglutide compared to placebo in older patients.
Important similarities and differences of 6 non-insulin antihyperglycemic drug classes were highlighted in a recently published meta-analysis.
The researchers found that in substitution or subtraction studies, total fructose-containing sugars had no harmful effect on any outcome, with a decrease in hemoglobin A1c in substitution studies (mean difference, −0.22%).
Prior to starting Xyosted, the patient's baseline cardiovascular risk should be considered and blood pressure should be adequately controlled.
Many Americans have "high-deductible" health insurance policies, which involves plans that require them to pay up to $7000 out-of-pocket annually if they utilize health care services.
Dapagliflozin was not associated with either a higher or lower rate of MACE compared with placebo in patients with type 2 diabetes who had or were at risk for atherosclerotic cardiovascular disease.
During her testimony, Dr E was asked about the notes in the chart, and she was forced to admit that she transcribed the scribble notes into the patient's record after the patient died and she had been contacted by the plaintiff's law firm asking for the records.
The study compared US administrative claims data of HCV patients with ≥12 weeks of dispensed DAA therapy (N=17,848) to untreated HCV patients with follow-up data (N=108,350).
Approximately 50% of deaths in people with type 2 diabetes worldwide, and approximately two-thirds of deaths in people with type 2 diabetes in the US are caused by cardiovascular disease.
The unadjusted prevalence rates of leisure-time physical inactivity and obesity were 56.5 and 50.1%, respectively, among adults with both arthritis and prediabetes.
"This is the first report of decreased insulin requirements in a patient with T1DM correlating with micafungin administration," noted the authors.
The new "F4" formulation is 4 times more concentrated than the version currently available on the market.
"We believe that the data actually suggest possible benefit for ESKD [end-stage kidney disease] with intensive glucose control, and remain inconclusive for intensive blood pressure control and fibrate use given the wide confidence intervals for the more reliable ESKD outcomes," write the authors.
Researchers found that, compared with several diabetes associations' official guidelines and other comparator diets, plant-based diets were correlated with significant improvements in emotional well-being, physical well-being, depression, and quality of life.
The effect of Invokana on CV risk was evaluated in the CANVAS (CANagliflozin cardioVascular Assessment Study) Program in >10,000 adults with T2D who had established CV disease or were at risk for CV disease with ≥2 risk factors.
The NDA included findings from multiple Phase 3 trials evaluating the safety, efficacy, and utility of the Xeris glucagon rescue pen auto-injector to treat severe hypoglycemia vs currently available glucagon emergency kits in children, adolescents, and adults with type 1 diabetes.
The randomized, double-blind, placebo-controlled, parallel-group study (N=9340) evaluated the time from randomization to first occurrence of major adverse CV events (MACE) (non-fatal heart attack, non-fatal stroke, CV death) in patients treated with liraglutide 1.8mg once daily or placebo.
The researchers concluded their findings indicate that for patients with RA, abatacept reduced the risk for diabetes and "potentially improved insulin sensitivity and glycemic profile."
The researchers found that at 24 months, the band group lost 10.7kg and the metformin group lost 1.7kg (P<.01). Furthermore, in the band group, insulin sensitivity increased 45% compared with 25% in the metformin group (P=.3 between groups).